Grasim stock: New plant adds 50,000 tonnes of capacity

Published on 10/30/2026 at 02:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Grasim stock is in focus after commercial production began at a new epichlorohydrin plant in Gujarat. The facility adds specialty chemicals capacity.

New capacity strengthens chemicals platform

Commercial production has started at Grasim's Vilayat epichlorohydrin facility.
The unit adds 50,000 tonnes of annual capacity to the specialty chemicals portfolio.
The project deepens integration with Grasim's chlor-alkali operations and the epoxy resin value chain.

Grasim, INE047A01021, Illustration mit AI erstellt.

Grasim Industries has started commercial production at a new epichlorohydrin facility in Vilayat, Gujarat, according to ETChemicals in a report published on October 28, 2026. The project is a new operating development for the company's specialty chemicals activities.

Vilayat adds epichlorohydrin capacity

The plant has installed capacity of 50,000 tonnes per year. Epichlorohydrin is an important feedstock for epoxy resins, which are used in applications including industrial coatings, construction chemicals, electronics and composite materials.

ETChemicals said the facility strengthens Grasim's position in the epoxy resin value chain and expands domestic supply of the intermediate. Those comments describe the plant's strategic relevance; the actual financial contribution will depend on the ramp-up of production, utilisation and market conditions.

Integration is central to the investment case

The Vilayat site is connected with Grasim's chlor-alkali and chlorine-derivatives operations. The resulting backward integration may support internal feedstock use and reduce reliance on external sourcing, although the report does not quantify any future cost savings or earnings effect.

For investors, the development adds another operational milestone to Grasim's broader specialty chemicals strategy. It should be assessed alongside execution risk, demand in downstream markets and the company's forthcoming financial disclosures rather than treated as a standalone earnings forecast.